Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas

Virchows Archiv

Volumn 433, Issue 2, 1998, Pages 119-129

  Malzahn, Karin ^a,c   Mitze, Margarete ^a,e   Thoenes, Martin ^a,d   Moll, Roland ^b,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Breast cancer; Cytokeratins; Intermediate filaments; Prognosis; Vimentin

Indexed keywords

CYTOKERATIN; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; VIMENTIN;

ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CELL INFILTRATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; EPITHELIUM; FEMALE; FROZEN SECTIONS; HUMANS; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; PROGNOSIS; RECEPTORS, ESTROGEN; VIMENTIN;

EID: 0031681356     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050226     Document Type: Article

References (59)

1. Aaltomaa S, Lipponen P (1992) Prognostic factors in breast cancer (review). Int J Oncol 1:153-159
2. Altmannsberger M, Dirk T, Droese M, Weber K, Osborn M (1986) Keratin polypeptide distribution in benign and malignant breast tumours: subdivision of ductal carcinomas using monoclonal antibodies.Virchows Arch [B] 51:265-275
3. Azumi N, Battifora H (1987) The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. Am J Clin Pathol 88:286-296
4. Bartek J, Durban EM, Hallowes RC, Taylor-Papadimitriou J (1985) A subclass of luminal epithelial cells in the human mammary gland, defined by antibodies to cytokeratins. J Cell Sci 75:17-33
5. Bell CD, Tischler EM, Laroye GJ (1995) The relationship of cytoplasmatic intermediate filaments and membrane antigens with hormone receptors, nuclear staining density, and mode of stromal invasion in human breast cancer. Breast Cancer Res Treat 33:147-162
6. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 9:359-377
7. Böcker W, Bier B, Freytag G, Brömmelkamp B, Jarasch ED, Edel G, Dockhorn-Dworniczak B, Schmid KW (1992) An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: epitheliosis and ductal carcinoma in situ. Virchows Arch [A] 421:323-330
8. Burke HB, Hutter RVP, Henson DE (1995) Breast carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds) Prognostic factors in cancer. Springer, Berlin Heidelberg New York, pp 165-176
9. Cattoretti G, Andreola S, Clemente C, D'Amato L, Rilke F (1988) Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br J Cancer 57:353-357
10. Cintorino M, Bugnoli M, Petracca R, Leoncini P (1988) Cytokeratin in normal and pathological bladder urothelium: Immunohistochemical investigation using monoclonal antibodies. J Urol 139:428-432
11. Cooper D, Schermer A, Sun T-T (1985) Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest 52:243-256
12. Dairkee SH, Ljung BM, Smith H, Hackett A (1987) Immunolocalisation of a human basal epithelium-specific keratin in benign and malignant breast disease. Breast Cancer Res Treat 10:11-20
13. Demirkesen C, Hoede N, Moll R (1995) Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemieal study including individual cytokeratins. J Cutan Pathol 22:518-535
14. Domagala W, Lasota J, Dukowicz A, Markiewski M, Striker G, Weber K, Osborn M (1990) Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am J Pathol 137:1299-1304
15. Gould VE, Koukoulis GK, Jansson DS, Nagle RB, Franke WW, Moll R (1990) Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic and neoplastic breast. Am J Pathol 137:1143-1155
16. Gown AM, Vogel AM (1985) Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. Am J Clin Pathol 84:413-424
17. Guelstein VI, Tchypysheva TA, Ermilova VD, Litvinova LV, Troyanovski SM, Bannikov GA (1988) Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. Int J Cancer 42:147-153
18. Heatley M, Maxwell P, Whiteside C, Toner P (1995) Cytokeratin intermediate filament expresssion in benign and malignant breast disease. J Clin Pathol 48:26-32
19. Henderson C, Harris JR, Kinne DW, Hellman S (1989) Cancer of the breast. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, vol 1. Lippincott, Philadelphia, pp 1197-1268
20. Hermanek P, Sobin LH (eds) (1992) TNM classification of malignant tumours, 4th edn. 2nd rev. Springer, Berlin Heidelberg New York for UICC, Geneva
21. Jarasch ED, Nagle RB, Kaufmann M, Maurer C, Böcker WJ (1988) Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol 19:276-289
22. Kalbfleisch JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley, New York, pp 1-320
23. Kaplan EL, Meier P (1958) Nonparametric estimation for incomplete information. Am Statist Assoc 53:457-481
24. Kaufmann O, Deidesheimer T, Muehlenberg M, Deicke P, Dietel M (1996) Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology 29:233-240
25. Knapp AC, Franke WW (1989) Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell 59:67-79
26. Koutselini H, Markopoulos C, Lambropoulou S, Gogas H, Kandaraki C, Gogas J (1995) Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients. Cytopathology 6:14-21
27. Martin de las Mulas J, Espinosa de los Monteras A, Bautista MJ, Gomez-Villamandos JC, Morales C (1994) Immunohistochemical distribution pattern of intermediate filament proteins and muscle actin in feline and human mammary carcinomas. J Comp Pathol 111:365-381
28. Moll R (1993) Cytokeratins as markers of differentiation: expression profiles in epithelia and epithelial tumors. Fischer, Stuttgart, pp 1-197
29. Moll R (1998) Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. In: Herrmann H, Harris JR, (eds) Subcellular biochemistry: intermediate filaments. Plenum, London (in press)
30. Moll R, Franke WW, Schiller D, Geiger B, Krepler R (1982) The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24
31. Moll R, Krepler R, Franke WW (1983) Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 23:256-269
32. Moll R, Hage G, Thoenes W (1991) Expression of intermediate filament proteins in fetal and adult human kidney: modulation of intermediate filament patterns during development and in damaged tissue. Lab Invest 65:74-86
33. Moll R, Löwe A, Laufer J, Franke WW (1992) Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427-447
34. Nagle RB (1994) A review of intermediate filament biology and their use in pathologic diagnosis. Mol Biol Rep 19:3-21
35. Nagle RB, Böcker W, Davis JR, Heid HW, Kaufmann M, Lucas DO, Jarasch ED (1986) Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem 34:869-881
36. Nathrath WBJ, Lane EB (1990) Immunhistologische Untersuchung der Verteilung von Cytokeratinen in 100 Mammacarcinomen. Verh Dtsch Ges Pathol 74:596
37. Nathrath WBJ, Reiss B, Lane EB (1994) Bedeutung verschiedener, insbesondere plattenepithelialer Keratinmuster in Mammakarzinomen. Verh Dtsch Ges Pathol 78:291
38. Page DL (1991) Prognosis and breast cancer: recognition of lethal and favorable prognostic types. Am J Surg Pathol 15:334-349
39. Patey DH, Dyson WH (1948) The prognosis of carcinoma of the breast in relation to the operation performed. Br J Cancer 2:7-13
40. Pellegrino MB, Asch BB, Conolly JL, Asch HL (1988) Differential expression of keratins 13 and 16 in normal epithelium, benign lesions and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12. Cancer Res 48:5831-5836
41. Purkis PE, Steel JB, Mackenzie IC, Nathrath WBJ, Leigh IM, Lane EB (1990) Antibody markers of basal cells in complex epithelia. J Cell Sci 97:39-50
42. Ramaekers FCS, van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, Schaart G, Vooijs P (1990) Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 136:641-655
43. Raymond WA, Leong AS-Y (1989) Vimentin - a new prognostic parameter in breast carcinoma? J Pathol (Sydney) 158:107-114
44. Santini D, Ceccarelli C, Taffurelli M, Pileri S, Marrano D (1996) Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J Pathol (Lond) 179:386-391
45. Schaafsma HE, Rameakers FCS (1994) Cytokeratin subtyping in normal and neoplastic epithelium: basic principles and diagnostic applications. Pathol Annu [I] 29:21-62
46. Schaller G, Fuchs I, Pritze W, Ebert A, Herbst H, Pantel K, Weitzel H, Lengyel E (1996) Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. Clin Cancer Res 2:1879-1885
47. Seshadri R, Raymond WA, Leong AS-Y, Horsfall DJ, McCaul K (1996) Vimentin expression is not associated with poor prognosis in breast cancer. Int J Cancer 67:353-356
48. Soini Y, Miettinen M (1992) Immunohistochemical evaluation of the cytoarchitecture of benign and malignant breast lesions. APMIS 100:901-907
49. Su L, Morgan PR, Lane EB (1996) Expression of cytokeratin messenger RNA versus protein in the normal mammary gland and in breast cancer. Hum Pathol 27:800-806
50. Takei H, Iino Y, Horiguchi J, Kanoh T, Takao Y, Oyama T, Morishita Y (1995) Immunohistochemical analysis of cytokeratin #8 as a prognostic factor in invasive breast carcinoma. Anticancer Res 15:1101-1106
51. Takei H, Iino Y, Horiguchi J, Maemura M, Oyama T, Yokoe T, Morishita Y (1997) Low and high molecular weight cytokeratins in invasive breast carcinomas. Oncol Rep 4:33-38
52. Thompson EW, Paik S, Brünner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippmann ME, Martin GR, Dickson RB (1992) Association of increased basement membrane invasiveness with absence of estrogene receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150:534-544
53. Trask DK, Band V, Zajchowski DA, Yaswen P, Suh T, Sager R (1990) Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci USA 87:2319-2323
54. Tsubura A, Okada H, Senzaki H, Hatano T, Morii S (1991) Keratin expression in the normal breast and in breast carcinoma. Histopathology 18:517-522
55. Wada T, Yasutomi M, Yamada K, Hashimura K, Kunikata M, Tanaka T, Jianwen H, Mori M (1991) Heterogeneity of keratin expression and actin distribution in benign and malignant mammmary diseases. Anticancer Res 11:1983-1994
56. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3:99-107
57. Weiss RA, Eichner R, Sun T-T (1984) Monoclonal antibody-analysis of keratin expression in epidermal diseases: a 48-and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 98:1397-1406
58. Wetzels RHW, Holland R, van Haelst UJGM, Lane EB, Leigh IM, Ramaekers FCS (1989) Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol 134:571-579
59. Wetzels RHW, Kuijpers HJH, Lane EB, Leigh IM, Troyanovsky SM, Holland R, van Haelst UJGM, Rameakers FCS (1991) Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol 138:751-763